| Issue Date | Title | Author(s) |
| 1-Aug-2019 | Assessment and management of infection in alcoholic hepatitis | Vergis, N; Thursz, M; Atkinson, S; |
| Nov-2020 | In severe alcoholic hepatitis, serum keratin-18 fragments are diagnostic, prognostic, and theragnostic biomarkers. | Atkinson, SR; Grove, JI; Liebig, S; Astbury, S; Vergis, N, et al |
| 16-Oct-2020 | Intestinal permeability and bacterial translocation in patients with liver disease, focusing on alcoholic aetiology: methods of assessment and therapeutic intervention | Skinner, C; Thompson, AJ; Thursz, MR; Marchesi, JR; Vergis, N, et al |
| 13-Jul-2020 | Letter: liver disease and COVID-19 - not the perfect storm | Nathwani, R; Mukherjee, S; Forlano, R; Mullish, BH; Vergis, N, et al |
| 27-Jul-2021 | Mitochondrial dysfunction and liver disease: role, relevance, and potential for therapeutic modulation | Middleton, P; Vergis, N; |
| 1-Apr-2019 | The future of therapy for alcoholic hepatitis - beyond corticosteroids | Vergis, N; Atkinson, S; Thursz, M; , et al |
| 30-Sep-2020 | Transcutaneous fluorescence spectroscopy as a tool for non-invasive monitoring of gut function: first clinical experiences | Maurice, J; Lett, A; Skinner, C; Lim, A; Richardson, M, et al |